PMV Pharma bags $74 mln Series B

Cranbury, New Jersey-based PMV Pharmaceuticals Inc, a developer of small molecule drugs that treat cancer, has closed $74 million in Series B financing. Topspin Biotech Fund led the round with participation from Euclidean Capital, InterWest Partners, OrbiMed Advisors and Osage University Partners.

Source: Press Release

Find new deal opportunities, super-charge your fundraising efforts and track top managers with VCJ. Get your FREE trial! Or subscribe now!